大约每三分钟，在美国，一个人被诊断出患有血液癌，总估计有170万人与今天相处或缓解。由于早期症状可能与不太严重的疾病混淆，目前的诊断测试通常是昂贵的，侵入性的，而且不可广泛的，因此新技术可能会引起新的呼吸。根据伦敦皇后大学（QMUL）科学家（QMUL）（QMUL）进行的一项研究，并在Hemasphere发表并在Hemasphere发表，简单而深刻的呼气可能会革新血液癌症的检测。 This first successful demonstration of spotting blood cancer-specific biomarkers in breath samples could lead to a tool that accelerates diagnosis, provides a low-cost alternative, and serves areas with limited access to specialist equipment.Blood Cancer Can Be Challenging to DetectThere are three main types of blood cancer, affecting different parts of the blood system: leukemia (affecting blood and bone marrow), lymphoma (affecting the lymphatic system), and myeloma （影响浆细胞），危险程度不同，具体取决于特定类型和个体因素，从高度可治愈到侵略性和威胁生命。每种治疗干预始于诊断，总的来说，这并不像人们希望的那样容易且早期制造。由于常见症状反映了每天的疾病，例如疲劳和体重减轻，所以尽早抓住它可能具有挑战性。 Besides wading through unclear early symptoms, diagnostic tools like imaging scans and biopsies are not widely accessible and can be expensive.Read More: Deadly Fungus That Haunted Ancient Tombs May Now Help Fight Against CancerUsing Breath to Diagnose CancerTo accelerate and simplify testing for blood cancer, the research team from QMUL were curious about how an already established method for another cancer type could be applied to blood cancer detection.“Previous studies have shown the value of using br